Letter: Cancer treatment plans should be unique

Published: 04-08-2025 2:18 PM

 

I recently joined dozens of cancer patients, survivors and their loved ones in connecting with New Hampshire state legislators as a part of the American Cancer Society Cancer Action Network’s (ACS CAN) Cancer Action Day, urging them to make access to precision medicine a top priority this session. I’m grateful my legislators, Representatives James Gruber, Susan DeLemus and Rick Devoid and Senator Daryl Abbas, spent time with me and listened as I explained how critical precision medicine services, like biomarker testing, are to end suffering and death from cancer. As a cancer patient of 16 years and an advocate, I understand that no cancer battle is the same! Every cancer diagnosis is unique, and patients’ treatment plans should reflect that. Biomarker testing allows oncologists to tailor treatments to a patient’s distinct cancer. Despite the evidence of its effectiveness, biomarker testing is unavailable to many. New Hampshire must equip its residents with the best tools to battle their cancer; we must prioritize expanding access to biomarker testing. State leaders should ensure that everyone in our state who needs it can access comprehensive biomarker testing. I hope this message was heard clearly in our meetings with lawmakers and that action is taken.

Michelle Lawrence

Henniker

Yesterday's Most Read Articles

City prepares to clear, clean longstanding encampments in Healey Park
State Supreme Court says towns can keep excess school taxes rather than sharing them with poorer towns
Ayotte signs expansion to school voucher program, eliminating income requirement
Four of New Hampshire’s 10 counties now deputized to work with ICE
Ayotte nominates Caitlin Davis as Frank Edelblut’s successor to lead state Department of Education
New fair coming next week to Everett Arena in Concord